Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Retroviral Agent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00221650
What this trial is testing

Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-infected Patients

Who this might be right for
HIV InfectionsHepatitis C, ChronicTreatment Failure
University Hospital, Bordeaux 17
Not applicableStudy completedNCT00001129
What this trial is testing

Two Adherence Plans to Help HIV-Positive Patients Take Their Medications Correctly

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,248
Early research (Phase 1)Study completedNCT00028132
What this trial is testing

Safety and Acceptability of the Anti-Microbe Vaginal Gel, PMPA Gel

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 120
Early research (Phase 1)UnknownNCT00006209
What this trial is testing

Tucaresol in HIV-Infected Patients Who Are Taking Other Anti-HIV Drugs

Who this might be right for
HIV Infections
Aaron Diamond AIDS Research Center 24
Testing effectiveness (Phase 2)Temporarily pausedNCT00004999
What this trial is testing

Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients

Who this might be right for
HIV Infections
Agouron Pharmaceuticals 350
Testing effectiveness (Phase 2)Study completedNCT00002227
What this trial is testing

Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Dupont Merck 60
Testing effectiveness (Phase 2)Study completedNCT00000885
What this trial is testing

Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 440
Not applicableStudy completedNCT00109603
What this trial is testing

Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy

Who this might be right for
HIV InfectionsDyslipidemiaHyperlipidemia+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 17
Early research (Phase 1)Study completedNCT00017758
What this trial is testing

The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs

Who this might be right for
HIV InfectionsHIV SeronegativityLipodystrophy
National Institute of Allergy and Infectious Diseases (NIAID) 56
Testing effectiveness (Phase 2)Study completedNCT00006604
What this trial is testing

Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 195
Not applicableStudy completedNCT00000943
What this trial is testing

Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 50
Not applicableUnknownNCT00011089
What this trial is testing

Tenofovir Disoproxil Fumarate in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drug Combinations

Who this might be right for
HIV Infections
Gilead Sciences
Post-approval studies (Phase 4)Study completedNCT00002386
What this trial is testing

Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia

Who this might be right for
HIV InfectionsHemophilia A
Merck Sharp & Dohme LLC 55
Not applicableStudy completedNCT00006490
What this trial is testing

A Comparison of Two Tests for Anti-HIV Drug Resistance

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 600
Not applicableStudy completedNCT00050089
What this trial is testing

CSP #512 - Options in Management With Anti-Retrovirals

Who this might be right for
AIDSHIV Infections
US Department of Veterans Affairs 368
Testing effectiveness (Phase 2)Study completedNCT00002213
What this trial is testing

The Safety and Effectiveness of 1592U89 Plus 141W94 Plus DMP 266 in Patients With HIV Who Developed a Resistance to Protease Inhibitors

Who this might be right for
HIV Infections
Glaxo Wellcome 80
Not applicableStudy completedNCT00000860
What this trial is testing

The Effects of Treatment for Mycobacterium Avium Complex (MAC) on the Cells of HIV-Infected Patients

Who this might be right for
Mycobacterium Avium-Intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)Study completedNCT00001118
What this trial is testing

Study of a New Anti-HIV Drug, T-20, in HIV-Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)Study completedNCT00000939
What this trial is testing

Compare the Effectiveness of Different Anti-HIV Drug Regimens in Keeping Levels of HIV in the Blood as Low as Possible

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 150
Testing effectiveness (Phase 2)Study completedNCT00002419
What this trial is testing

Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment

Who this might be right for
HIV Infections
Gilead Sciences 25
Next Page